AGILE THERAPEUTICS INC Annual Nonoperating Income (Expense) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Agile Therapeutics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2015 to 2023.
  • Agile Therapeutics Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$9.13M, a 793% decline year-over-year.
  • Agile Therapeutics Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$2.3M, a 113% decline year-over-year.
  • Agile Therapeutics Inc annual Nonoperating Income (Expense) for 2023 was $5.42M, a 75.9% decline from 2022.
  • Agile Therapeutics Inc annual Nonoperating Income (Expense) for 2022 was $22.5M.
  • Agile Therapeutics Inc annual Nonoperating Income (Expense) for 2021 was -$62K, a 97.8% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.42M -$17.1M -75.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $22.5M +$22.5M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$62K +$2.74M +97.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 -$2.8M -$3.05M -1211% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $252K +$973K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
2018 -$721K +$772K +51.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$1.49M +$602K +28.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-20
2016 -$2.1M +$1.12M +34.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 -$3.22M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.